I-131-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma

---

Copy For Citation

Gedik G. K., Hoefnagel C. A., Bais E., Olmos R. A. V.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.35, no.4, pp.725-733, 2008 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 35 Issue: 4
• Publication Date: 2008
• Doi Number: 10.1007/s00259-007-0652-6
• Journal Name: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.725-733
• Hacettepe University Affiliated: Yes

Abstract

Purpose (131)Iodine metaiodobenzylguanidine (I-131-MIBG) is a radiopharmaceutical used for scintigraphic localisation of phaeochromocytomas and paragangliomas. The experience with its therapeutic use is limited. We report our experience for the treatment of malignant phaeochromocytoma and paraganglioma.